Skip to content.

Companies

Acquired by KnowBe4

Acquired by Apple

Acquired by Capital D

Acquired by Oracle

Acquired by Siemens

Acquired by ERT Inc

IPO: AREC

IPO: ORTX

IPO: FRLN

IPO: ACHL

IPO: MGTX

Acquired by Facebook

IPO: BKNG

  • University Spinouts investments
  • Established
    2016
    In collaboration with UCL Business
  • Total investment
    > $2bn
    Over $2bn of follow on funding for portfolio
  • Public offerings
    4 IPOs
    Four NASDAQ IPOs since 2018

Featured investments

Universities should not be greedy with technology spin-offs | FT

Dave Grimm, Partner at AlbionVC, chats to John Gapper, Financial Times, on the opportunities that commercialising research presents, on the back of our very successful partnership with UCL.

Read the article >

UK universities take record low spinout stakes: ‘But that’s only half the battle’

David Grimm, Partner AlbionVC discusses university spinout terms and timelines with Sifted

Read the article >

Today, 90% of Russell Group universities have affiliated funds as reported by Sifted

Why We’re Bullish on London University Spinouts

Read the article >
Companies
  • Achilles Therapeutics
    Biopharmaceutical company developing precision T cell therapies
    Sector: University Spinouts
    Status: IPO
  • biopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs
    Sector: University Spinouts
    Status: Growth
  • Gene therapy company developing disease-transformative medicines for ciliopathies
    Sector: University Spinouts
    Status: Early Stage
  • Bloomsbury AI
    Enabling everyone to easily create their own question-answering system
    Sector: University Spinouts
    Status: Exited
  • Biotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases
    Sector: University Spinouts
    Status: Early Stage
  • Fuel cell company on a mission to help the world achieve net zero
    Sector: University Spinouts
    Status: Growth
  • Climate tech startup utilising AI to achieve operational efficiency in energy intensive industries
    Sector: University Spinouts
    Status: Early Stage
  • Transforming interventional cardiology with optical-fibre based sensors
    Sector: University Spinouts
    Status: Growth
  • Biotechnology company developing of cutting-edge gene therapies to treat focal refractory epilepsy
    Sector: University Spinouts
    Status: Early Stage
  • Immuno-oncology company targeting cancer with the IgE class of antibodies
    Sector: University Spinouts
    Status: Early Stage
  • Revolutionising batteries through magneto-electrochemistry: MagLiB technology.
    Sector: University Spinouts
    Status: Growth
  • Synthetic data platform
    Sector: University Spinouts
    Status: Exited
  • Software development company that helps businesses build and test AI applications based on large language models (LLMs)
    Sector: University Spinouts
    Status: Early Stage
  • Developing a new type of all silicon non-volatile memory
    Sector: University Spinouts
    Status: Early Stage
  • Vertically integrated, clinical stage gene therapy company
    Sector: University Spinouts
    Status: IPO
  • Immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer
    Sector: University Spinouts
    Status: Early Stage
  • AI powered platform that unifies large datasets and automatically optimises sales performance for marketplace sellers
    Sector: University Spinouts
    Status: Exited
  • Builds a new era of cloud connected endoscopy
    Sector: University Spinouts
    Status: Exited
  • Orchard Therapeutics
    Biotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases
    Sector: University Spinouts
    Status: IPO
  • UCL spinout using light to train LLMs a hundred times faster with only a fraction of power
    Sector: University Spinouts
    Status: Growth
  • Panangium Therapeutics
    Biologic for retinal disease targeting a novel alternative pathway to VEGF
    Sector: University Spinouts
    Status: Early Stage
  • Using disruptive theory to unlock the power of quantum computing
    Sector: University Spinouts
    Status: Growth
  • Software company simplifying graph analytics for businesses
    Sector: University Spinouts
    Status: Early Stage
  • Quell Therapeutics
    A clinical stage company transforming lives in immune mediated disease
    Sector: University Spinouts
    Status: Growth
  • Biopharmaceutical company focused on the development of liver-directed gene therapies
    Sector: University Spinouts
    Status: IPO
  • AI startup leveraging active inference and the free energy principle to build ‘Agentic AI’ for the real world.
    Sector: University Spinouts
    Status: Early Stage
  • EdTech platform connecting tutors in the developing countries to students in developed economies
    Sector: University Spinouts
    Status: Early Stage

Let’s connect